- Advertisement -
Three doses of the Pfizer/BioNTech vaccine are likely to protect against infection with the Omicron variant but two doses may not, according to laboratory data that will increase pressure to speed up booster programmes.
Tests using antibodies in blood samples have given some of the first insights…

